# University of Exeter

Organization · id `cardio:org-university-of-exeter` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ROR record 03yghzc09](<https://ror.org/03yghzc09>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.

## Technical summary

Sponsor class other. Matched to ROR record 03yghzc09 by an exact name.

## The registry's words

- Sponsor name: University of Exeter
- Sponsor class: OTHER
- ROR name: University of Exeter

## Connected pages

- Sponsors: MASTERMIND - Understanding Individual Variation in Treatment Response in Type 2 Diabetes (`cardio:ct-nct01847144`)
- Sponsors: TriMaster: Study of a DPP4 Inhibitor, SGLT2 Inhibitor and Thiazolidinedione as Third Line Therapy in Patients With Type 2 Diabetes. (`cardio:ct-nct02653209`)
- Sponsors: Mobile Health to Enhance Exercise in Type 2 Diabetes (`cardio:ct-nct04653532`)

## Provenance

Content hash: 6dfa4ec363b2ce452c731754179733352e556561c0bd2465cc38ffd7ddab30b5
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
